| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cipher Pharmaceuticals Inc (TO: CPH)
CPH Technical Analysis
5
| As on 18th Nov 2024 CPH STOCK Price closed @ 14.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.59 & Strong Buy for SHORT-TERM with Stoploss of 3.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CPHSTOCK Price
| Open | 14.27 | Change | Price | % |
| High | 14.67 | 1 Day | 0.83 | 6.07 |
| Low | 13.68 | 1 Week | -1.04 | -6.69 |
| Close | 14.50 | 1 Month | -1.25 | -7.94 |
| Volume | 69767 | 1 Year | 10.60 | 271.79 |
| 52 Week High 18.99 | 52 Week Low 3.44 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| ENB | 60.79 | 1.40% |
| CNQ | 48.30 | 2.31% |
| MFC | 45.33 | -1.56% |
| UEX | 0.50 | 16.28% |
| SU | 57.21 | 0.02% |
| CVE | 22.64 | 0.98% |
| SJR-B | 40.48 | 0.02% |
| AC | 23.97 | -2.16% |
| BCE | 37.27 | -1.25% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| CPH Daily Charts |
CPH Intraday Charts |
Whats New @ Bazaartrend |
CPH Free Analysis |
|
|
CPH Important Levels Intraday
| RESISTANCE | 16.41 |
| RESISTANCE | 15.80 |
| RESISTANCE | 15.42 |
| RESISTANCE | 15.04 |
| SUPPORT | 13.96 |
| SUPPORT | 13.58 |
| SUPPORT | 13.20 |
| SUPPORT | 12.59 |
CPH Forecast November 2024
| 4th UP Forecast | 15.52 |
| 3rd UP Forecast | 15.19 |
| 2nd UP Forecast | 14.99 |
| 1st UP Forecast | 14.79 |
| 1st DOWN Forecast | 14.21 |
| 2nd DOWN Forecast | 14.01 |
| 3rd DOWN Forecast | 13.81 |
| 4th DOWN Forecast | 13.48 |
CPH Weekly Forecast
| 4th UP Forecast | 15.00 |
| 3rd UP Forecast | 14.84 |
| 2nd UP Forecast | 14.74 |
| 1st UP Forecast | 14.64 |
| 1st DOWN Forecast | 14.36 |
| 2nd DOWN Forecast | 14.26 |
| 3rd DOWN Forecast | 14.16 |
| 4th DOWN Forecast | 14.00 |
CPH Forecast2024
| 4th UP Forecast | 46.08 |
| 3rd UP Forecast | 35.95 |
| 2nd UP Forecast | 29.69 |
| 1st UP Forecast | 23.43 |
| 1st DOWN Forecast | 5.57 |
| 2nd DOWN Forecast | -0.69 |
| 3rd DOWN Forecast | -6.95 |
| 4th DOWN Forecast | -17.08 |
Cipher Pharmaceuticals Inc ( TO Canada Symbol : CPH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CPH Business Profile
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products also include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada. Address: 209 Oak Park Boulevard, Oakville, ON, Canada, L6H 0M2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service